Digital Biomarkers: Shaping the Future of Rare Diseases

• Discuss the strategic value and transformative impact of digital biomarkers in rare disease development
• Tackle the key challenges and mitigations to deployment and validation of digital endpoints in CNS studies
• Enable adoption through fit‑for‑purpose evidence strategies

Speakers:

Jessica nakhle

Director, Head of Clinical Biomarkers Neuroscience & Immuno-inflammation, Translational Medicine

Servier